Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.
2.

Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.

Plosker GL, Figgitt DP.

Drugs. 2003;63(8):803-43. Review.

PMID:
12662126
3.

High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.

Schaaf M, Reiser M, Borchmann P, Engert A, Skoetz N.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD007678. doi: 10.1002/14651858.CD007678.pub2. Review.

PMID:
22258971
4.

Primary follicular lymphoma of the gastrointestinal tract.

Misdraji J, Harris NL, Hasserjian RP, Lauwers GY, Ferry JA.

Am J Surg Pathol. 2011 Sep;35(9):1255-63. doi: 10.1097/PAS.0b013e318224e661.

PMID:
21836483
5.

A phase 2 trial of extended induction epratuzumab and rituximab for previously untreated follicular lymphoma: CALGB 50701.

Grant BW, Jung SH, Johnson JL, Kostakoglu L, Hsi E, Byrd JC, Jones J, Leonard JP, Martin SE, Cheson BD.

Cancer. 2013 Nov 1;119(21):3797-804. doi: 10.1002/cncr.28299. Epub 2013 Aug 6.

6.

How have outcomes for patients with follicular lymphoma changed with the addition of monoclonal antibodies?

Illidge T, Chan C.

Leuk Lymphoma. 2008 Jul;49(7):1263-73. doi: 10.1080/10428190802090805. Review.

PMID:
18604715
7.

Treatment of follicular lymphoma: current status.

Tilly H, Zelenetz A.

Leuk Lymphoma. 2008;49 Suppl 1:7-17. doi: 10.1080/10428190802311391. Review.

PMID:
18821428
8.

Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.

Papaioannou D, Rafia R, Rathbone J, Stevenson M, Buckley Woods H, Stevens J.

Health Technol Assess. 2012;16(37):1-253, iii-iv. Review.

9.

Diagnosis and treatment of follicular lymphoma.

Hitz F, Ketterer N, Lohri A, Mey U, Pederiva S, Renner C, Taverna C, Hartmann A, Yeow K, Bodis S, Zucca E.

Swiss Med Wkly. 2011 Aug 4;141:w13247. doi: 10.4414/smw.2011.13247. Review.

10.

Treatment of follicular non-Hodgkin's lymphoma: the old and the new.

Friedberg JW.

Semin Hematol. 2008 Jul;45(3 Suppl 2):S2-6. doi: 10.1053/j.seminhematol.2008.07.003. Review.

11.

Idiotype vaccine strategies for improving outcomes in follicular lymphoma.

Sinha R, Shenoy PJ, Flowers CR.

Expert Opin Biol Ther. 2008 Aug;8(8):1213-23. doi: 10.1517/14712598.8.8.1213 . Review.

PMID:
18613772
12.

Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with (131)I-anti-CD20 antibody and stem cell rescue.

Hohloch K, Sahlmann CO, Lakhani VJ, Wulf G, Glass B, Hasenkamp J, Meller J, Riggert J, Trümper L, Griesinger F.

Ann Hematol. 2011 Nov;90(11):1307-15. doi: 10.1007/s00277-011-1199-y. Epub 2011 Mar 1.

PMID:
21360108
13.

The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United States.

Nastoupil LJ, Sinha R, Byrtek M, Zhou X, Taylor MD, Friedberg JW, Link BK, Cerhan JR, Dawson K, Flowers CR.

Cancer. 2014 Jun 15;120(12):1830-7. doi: 10.1002/cncr.28659. Epub 2014 Mar 25.

14.

Treatment recommendations for radioimmunotherapy in follicular lymphoma: a consensus conference report.

Witzig TE, Fishkin P, Gordon LI, Gregory SA, Jacobs S, Macklis R, McLaughlin P, Press O, Zelenetz AD.

Leuk Lymphoma. 2011 Jul;52(7):1188-99. doi: 10.3109/10428194.2011.570396. Epub 2011 May 23. Review.

PMID:
21599576
15.

Rituximab maintenance versus radioimmunotherapy consolidation in follicular lymphoma: which, when, and for whom?

Forstpointner R, Dreyling M.

Curr Hematol Malig Rep. 2011 Dec;6(4):207-15. doi: 10.1007/s11899-011-0099-5. Review.

PMID:
21909660
16.

Management options for follicular lymphoma: observe; R-CHOP; B-R; others?

McLaughlin P.

Clin Lymphoma Myeloma Leuk. 2011 Jun;11 Suppl 1:S91-5. doi: 10.1016/j.clml.2011.04.006. Epub 2011 May 14. Review.

PMID:
22035757
17.

High anti-lymphoma activity of bendamustine/mitoxantrone/rituximab in rituximab pretreated relapsed or refractory indolent lymphomas and mantle cell lymphomas. A multicenter phase II study of the German Low Grade Lymphoma Study Group (GLSG).

Weide R, Hess G, Köppler H, Heymanns J, Thomalla J, Aldaoud A, Losem C, Schmitz S, Haak U, Huber C, Unterhalt M, Hiddemann W, Dreyling M; German Low Grade Lymphoma Study Group.

Leuk Lymphoma. 2007 Jul;48(7):1299-306.

PMID:
17613757
19.

Treatment strategies in follicular lymphomas: current status and future perspectives.

Hiddemann W, Buske C, Dreyling M, Weigert O, Lenz G, Forstpointner R, Nickenig C, Unterhalt M.

J Clin Oncol. 2005 Sep 10;23(26):6394-9. Review.

PMID:
16155025
20.

Chemotherapy-free treatment in patients with follicular lymphoma.

Sarkozy C, Salles G, Bachy E.

Expert Rev Hematol. 2015 Apr;8(2):187-203. doi: 10.1586/17474086.2015.998995. Epub 2015 Jan 13. Review.

PMID:
25585961

Supplemental Content

Support Center